Research programme: urinary incontinence therapy - UCB
Alternative Names: 101264Latest Information Update: 20 Jul 2007
At a glance
- Originator UCB
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Urinary incontinence
Most Recent Events
- 17 Jun 2005 Preclinical trials in Urinary incontinence in Germany (unspecified route)